Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when ENvue Medical, Inc. publishes a filing, an earnings call transcript or a press release.

Get FEED alerts

About David Johnson

David Johnson is recorded as Board Member at ENvue Medical, Inc. (FEED) since December 4, 2025, Chairman at ENvue Medical, Inc. (FEED), Board Member at Arthur J. Gallagher & Co. (AJG), CFO at Rank One Computing Corp (ROC), Board Member at Caribou Biosciences, Inc. (CRBU), COO at Vera Therapeutics, Inc. (VERA), Board Member at Aura Biosciences, Inc. (AURA) since January 1, 2021, CEO and Board Member at Enveric Biosciences, Inc. (ENVB) since December 30, 2020 and Board Member at Zentalis Pharmaceuticals, Inc. (ZNTL) since January 1, 2020. The newest filing on record that lists David Johnson as Chairman at ENvue Medical, Inc. (FEED) is dated November 10, 2025. The newest filing on record that lists David Johnson as Board Member at Arthur J. Gallagher & Co. (AJG) is dated March 23, 2026. ENvue Medical, Inc. reported in an 8-K filed July 14, 2026 that David Johnson resigned as member of the Board of Directors, effective July 14, 2026. ENvue Medical, Inc. reported in an 8-K filed February 6, 2026 that David Johnson was appointed Chairman of the Company's Board of Directors, effective February 2, 2026. ENvue Medical, Inc. reported in an 8-K filed December 5, 2025 that David Johnson was appointed director, effective December 4, 2025. Equibles holds 4 filed executive changes naming David Johnson; each is listed under recent activity with its source filing. The proxy statement of Vera Therapeutics, Inc. reports total compensation of $2,721,412 for David Johnson in fiscal 2025, including a base salary of $510,000. Disclosed compensation is on record for 3 fiscal years. David Johnson has spoken on 1 earnings call across 1 company, most recently for Rank One Computing Corp on September 30, 2025. Arthur J. Gallagher & Co. is classified in the Insurance Brokers industry within the Financial Services sector. Aura Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rank One Computing Corp includes Dr. Anil Jain (Board Member) and Dr. Kathleen L. Kiernan (Board Member).

“On July 14, 2026, each of David Johnson and Nino Pionati voluntarily resigned from their respective positions as members of the Board of Directors (the "Board") of ENvue Medical, Inc. (the "Company").”
ENvue Medical, Inc. Form 8-K, filed July 14, 2026 · Read the filing
“On February 2, 2026, the Company entered into a chairman agreement with David Johnson (the "Chairman Agreement"), pursuant to which Mr. Johnson shall serve as the Chairman of the Company's Board of Directors (the "Board").”
ENvue Medical, Inc. Form 8-K, filed February 6, 2026 · Read the filing

David Johnson on recent calls

“In yesterday's earnings release, we provided detailed third quarter and 9-month financial tables. So I'll use this time to offer further insight into specific financial metrics.”
CFO, Rank One Computing Corp Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Current role

Medical Devices · Healthcare

Chairman, Board Member

2025-12-04–present

Current role

Drug Manufacturers - General · Healthcare

Leadership on record at Rank One Computing Corp

Leadership on record at Arthur J. Gallagher & Co.

Leadership on record at Aura Biosciences, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Vera Therapeutics, Inc. (VERA) $510,000 $2,721,412
2024 Vera Therapeutics, Inc. (VERA) — —
2023 Vera Therapeutics, Inc. (VERA) — —

Recent activity